Preventing HIV infection

British Medical Journal

Volumn 331, Issue 7528, 2005, Pages 1285-1286

  Jones, Rachael ^a   Gazzard, Brian ^a   Halima, Yasmin ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE; TENOFOVIR;

BREAST FEEDING; CHEMOPROPHYLAXIS; CIRCUMCISION; CLINICAL TRIAL; DRUG INDUSTRY; EDITORIAL; FOLLOW UP; GOVERNMENT; HEALTH BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PREVALENCE; PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SEXUAL BEHAVIOR; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 28544447404     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.331.7528.1285     Document Type: Editorial

References (13)

1. Creese A, Floyd K, Alban A, Guiness L. Cost effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002;359:1635-42.
2. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003;361:645-52.
3. Jiang S, Liu S, Lu H, Neurath AR. Synergistic and complementary effects of the anti-HIV-1 microbicides CAP and UC781 in combination. IAS Conference on HIV Pathogenesis and treatment, Rio de Janeiro, 2005:abstract MoPp0103.
4. Halperin DT, Bailey RC. Male circumcision and HIV infection: 10 years and counting. Lancet 1999;354:1813-5.
5. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005;2(11):e298.
6. Tsai CC, Follis KE, Sabo A, Beck TW, Grant RF, Bischofberger N, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science 1995;270:1197-9.
7. Subbarao S. Chemoprophylaxis with oral tenofovir dispropoxil fumarate delays but does not prevent infection in rhesus macaques given repeated rectal challenges of SHIV. Twelfth Conference on Retroviruses and Opportunistic Infections, Boston, 2005:abstract 136LB.
8. Cohen J. AIDS research. Cambodian leader throws novel prevention trial into limbo. Science 2004;305:1092.
9. Ahmed K. Trial of antiretroviral for HIV prevention on hold. Lancet Infect Dis 2004;4:597
10. Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, et al. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS 2000;14:111-5.
11. McIntyre JA, Martinson N, Gray GE, Hopley M, Kimira T, Robinson P, et al. Addition of short course Combivir to single dose Viramune for the prevention of mother to child transmission of HIV-1 can significantly decrease the subsequent development of maternal and paediatric NNRTI-resistant virus. 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 2005:abstract TuFoO2O4.
12. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV transmission and increases HIV-free survival. AIDS 2005;19:699-708.
13. European Collaborative Study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001;15:761-70.